Health Canada drug identification number

DIN 02502321 — SUBOXONE 1 MG; 4 MG

SUBOXONE is a film (soluble) of Buprenorphine / Naloxone marketed by INDIVIOR UK LIMITED. The full Buprenorphine / Naloxone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02502321
Brand name
SUBOXONE
Active ingredient
Buprenorphine / Naloxone
Strength
1 MG; 4 MG
Dosage form
FILM (SOLUBLE)
Route
BUCCAL; SUBLINGUAL
Manufacturer
INDIVIOR UK LIMITED
Health Canada status
MARKETED
Drug class
Opioid partial agonist / opioid antagonist combination

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Buprenorphine / Naloxone products

DINBrandStrengthFormManufacturerStatus
02424851 PMS-BUPRENORPHINE-NALOXONE 2 MG; 0.5 MG TABLET PHARMASCIENCE INC MARKETED
02424878 PMS-BUPRENORPHINE-NALOXONE 2 MG; 8 MG TABLET PHARMASCIENCE INC MARKETED
02468085 SUBOXONE 12 MG; 3 MG TABLET INDIVIOR UK LIMITED MARKETED
02502356 SUBOXONE 12 MG; 3 MG FILM (SOLUBLE) INDIVIOR UK LIMITED MARKETED
02295695 SUBOXONE 2 MG; 0.5 MG TABLET INDIVIOR UK LIMITED MARKETED
02502313 SUBOXONE 2 MG; 0.5 MG FILM (SOLUBLE) INDIVIOR UK LIMITED MARKETED
02502348 SUBOXONE 2 MG; 8 MG FILM (SOLUBLE) INDIVIOR UK LIMITED MARKETED
02468093 SUBOXONE 4 MG; 16 MG TABLET INDIVIOR UK LIMITED MARKETED
02295709 SUBOXONE 8 MG; 2 MG TABLET INDIVIOR UK LIMITED MARKETED
02453908 TEVA-BUPRENORPHINE/NALOXONE 0.5 MG; 2 MG TABLET TEVA CANADA LIMITED MARKETED
02453916 TEVA-BUPRENORPHINE/NALOXONE 8 MG; 2 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.